CRISPR/Cas9 DNA cleavage at SNP-derived PAM enables both in vitro and in vivo KRT12 mutation-specific targeting. (2016)

First Author: Courtney DG
Attributed to:  Developing targeted therapeutics for keratinizing skin disorders funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/gt.2015.82

PubMed Identifier: 26289666

Publication URI: http://europepmc.org/abstract/MED/26289666

Type: Journal Article/Review

Volume: 23

Parent Publication: Gene therapy

Issue: 1

ISSN: 0969-7128